Clinical Trial: Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598214) titled 'Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients' on Feb. 01.

Brief Summary: The current study aims to investigate the protective properties of diosmin/hesperidin on cisplatin-induced nephrotoxicity.

Study Start Date: Feb. 03, 2025

Study Type: INTERVENTIONAL

Condition: Cancer Patients

Intervention: COMBINATION_PRODUCT: diosmin/hesperdin

combination of Diosmin and Hesperidin

Recruitment Status: RECRUITING

Sponsor: Beni-Suef University

Information provided by (Responsible Party): Hasnaa Osama, Beni-Suef University

Published by HT Digital Content Services with permission fr...